Tekla Healthcare Investors Stock Current Valuation
| HQH Stock | USD 16.72 0.09 0.54% |
Valuation analysis of Tekla Healthcare Inv helps investors to measure Tekla Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The Tekla Healthcare's current Enterprise Value is estimated to increase to about 1 B. Fundamental drivers impacting Tekla Healthcare's valuation include:
Fairly Valued
Today
Please note that Tekla Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Tekla Healthcare Inv is based on 3 months time horizon. Increasing Tekla Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Tekla Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tekla Stock. However, Tekla Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.72 | Real 16.33 | Hype 16.7 | Naive 16.79 |
The intrinsic value of Tekla Healthcare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Tekla Healthcare's stock price.
Estimating the potential upside or downside of Tekla Healthcare Investors helps investors to forecast how Tekla stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tekla Healthcare more accurately as focusing exclusively on Tekla Healthcare's fundamentals will not take into account other important factors: Tekla Healthcare Investors Company Current Valuation Analysis
Tekla Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Tekla Healthcare Current Valuation | 866.92 M |
Most of Tekla Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tekla Healthcare Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Tekla Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Tekla Healthcare is extremely important. It helps to project a fair market value of Tekla Stock properly, considering its historical fundamentals such as Current Valuation. Since Tekla Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tekla Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tekla Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
Tekla Current Valuation Historical Pattern
Today, most investors in Tekla Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tekla Healthcare's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Tekla Healthcare current valuation as a starting point in their analysis.
Tekla Healthcare Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Tekla Healthcare Investors has a Current Valuation of 866.92 M. This is 97.36% lower than that of the Capital Markets sector and 88.41% lower than that of the Financials industry. The current valuation for all United States stocks is 94.79% higher than that of the company.
Tekla Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tekla Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tekla Healthcare could also be used in its relative valuation, which is a method of valuing Tekla Healthcare by comparing valuation metrics of similar companies.Tekla Healthcare is currently under evaluation in current valuation category among its peers.
Tekla Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Tekla Healthcare from analyzing Tekla Healthcare's financial statements. These drivers represent accounts that assess Tekla Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Tekla Healthcare's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 894.2M | 1.0B | 1.1B | 819.3M | 836.7M | 1.0B | |
| Enterprise Value | 892.6M | 1.0B | 1.1B | 819.3M | 836.7M | 1.0B |
Tekla Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Tekla Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Tekla Healthcare's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Tekla Fundamentals
| Return On Equity | 0.19 | ||||
| Return On Asset | -1.0E-4 | ||||
| Profit Margin | 17.17 % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 866.92 M | ||||
| Shares Outstanding | 52.13 M | ||||
| Shares Owned By Institutions | 23.89 % | ||||
| Number Of Shares Shorted | 92.28 K | ||||
| Price To Earning | 3.38 X | ||||
| Price To Book | 0.82 X | ||||
| Price To Sales | 80.50 X | ||||
| Revenue | 10.77 M | ||||
| Gross Profit | 10.77 M | ||||
| EBITDA | 56.33 M | ||||
| Net Income | 184.95 M | ||||
| Cash And Equivalents | 62 | ||||
| Total Debt | 1.4 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 3.21 X | ||||
| Book Value Per Share | 20.33 X | ||||
| Cash Flow From Operations | (65.41 M) | ||||
| Short Ratio | 0.71 X | ||||
| Earnings Per Share | 3.53 X | ||||
| Beta | 0.75 | ||||
| Market Capitalization | 866.92 M | ||||
| Total Asset | 1.06 B | ||||
| Retained Earnings | 117.95 M | ||||
| Annual Yield | 0.14 % | ||||
| Five Year Return | 8.90 % | ||||
| Net Asset | 1.06 B | ||||
| Last Dividend Paid | 2.04 |
About Tekla Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla Healthcare Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Healthcare Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:Check out Tekla Healthcare Piotroski F Score and Tekla Healthcare Altman Z Score analysis. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.145 | Dividend Share 2.04 | Earnings Share 3.53 | Revenue Per Share | Quarterly Revenue Growth 0.172 |
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.